Monica Sikka

Assistant Professor

  • 184 Citations
  • 7 h-Index
19982019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Monica Sikka is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Serratia marcescens Medicine & Life Sciences
Bacteremia Medicine & Life Sciences
Syringes Medicine & Life Sciences
Klebsiella pneumoniae Medicine & Life Sciences
Long-Term Care Medicine & Life Sciences
Ebola Hemorrhagic Fever Medicine & Life Sciences
Enterobacteriaceae Medicine & Life Sciences
Human Influenza Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2019

  • 184 Citations
  • 7 h-Index
  • 16 Article

Dalbavancin use in an academic medical centre and associated cost savings

Streifel, A. C., Sikka, M., Bowen, C. D. & Lewis, J. S., Jan 1 2019, (Accepted/In press) In : International Journal of Antimicrobial Agents.

Research output: Contribution to journalArticle

Cost Savings
Anti-Bacterial Agents
Health Expenditures
Retrospective Studies
Delivery of Health Care
2 Citations (Scopus)

Experience of Chicagoland acute care hospitals in preparing for Ebola virus disease, 2014–2015

Bleasdale, S. C., Sikka, M., Moritz, D. C., Fritzen-Pedicini, C., Stiehl, E., Brosseau, L. M. & Jones, R. M., Aug 3 2019, In : Journal of Occupational and Environmental Hygiene. 16, 8, p. 582-591 10 p.

Research output: Contribution to journalArticle

Ebola Hemorrhagic Fever
Delivery of Health Care
Disease Outbreaks
Communicable Diseases
Personal Protective Equipment

Utilizing the focused conversation method in qualitative public health research: A team-based approach

Fritzen-Pedicini, C., Bleasdale, S. C., Brosseau, L. M., Moritz, D., Sikka, M., Stiehl, E. & Jones, R. M., May 14 2019, In : BMC health services research. 19, 1, 306.

Research output: Contribution to journalArticle

Open Access
Public Health
Research
Ebola Hemorrhagic Fever
Delivery of Health Care
Lenses
3 Citations (Scopus)

Pharmacokinetics of telavancin at fixed doses in normal- body-weight and obese (classes I, II, and III) adult subjects

Bunnell, K. L., Pai, M. P., Sikka, M., Bleasdale, S. C., Wenzler, E., Danziger, L. H. & Rodvold, K. A., Apr 1 2018, In : Antimicrobial Agents and Chemotherapy. 62, 4, e02475-17.

Research output: Contribution to journalArticle

Open Access
Ideal Body Weight
Pharmacokinetics
Body Weight
Body Mass Index
telavancin
1 Citation (Scopus)

Phase I study to evaluate the pharmacokinetics, safety, and tolerability of two dosing regimens of oral fosfomycin tromethamine in healthy adult participants

Antibacterial Resistance Leadership Group, Aug 1 2018, In : Antimicrobial Agents and Chemotherapy. 62, 8, e00464-18.

Research output: Contribution to journalArticle

Fosfomycin
Healthy Volunteers
Pharmacokinetics
Urine
Safety